Equities

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc

Actions
  • Price (EUR)82.43
  • Today's Change2.03 / 2.52%
  • Shares traded37.00
  • 1 Year change+23.95%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year GE Healthcare Technologies Inc had net income fall -18.16% from 1.92bn to 1.57bn despite a 6.60% increase in revenues from 18.34bn to 19.55bn.
Gross margin41.33%
Net profit margin8.84%
Operating margin12.85%
Return on assets5.22%
Return on equity21.69%
Return on investment6.97%
More ▼

Cash flow in USDView more

In 2023, GE Healthcare Technologies Inc increased its cash reserves by 72.71%, or 1.06bn. The company earned 2.10bn from its operations for a Cash Flow Margin of 10.75%. In addition the company used 558.00m on investing activities and also paid 478.00m in financing cash flows.
Cash flow per share5.04
Price/Cash flow per share16.98
Book value per share18.20
Tangible book value per share-13.03
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)3.34%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
8.36
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.